Empagliflozin 10 mg Tablet

Adult dose

For type 2 diabetes, take 10 mg once daily as monotherapy and in addition to other hypoglycemic agents like insulin. If tolerance is good and further blood sugar control is needed, the dosage can be increased to 25 mg once daily. For chronic heart failure and chronic kidney disease, take 10 mg once daily. This medication can be taken irrespective of meals and should be swallowed whole.

This medication should not be used by those who are allergic to the active ingredient or any of the components. It should not be administered to type 1 diabetes patients or those with diabetic ketoacidosis, and patients who genetically cannot digest lactose should not take this medication. For patients with poor kidney function, kidney function should be regularly monitored while using this medication, and it is not recommended for patients with severely low kidney function. There is a risk of hypoglycemia when taken with insulin or insulin-secreting medications, so dose adjustment may be necessary. Patients should be carefully monitored for side effects such as hypoglycemia, infections, especially genital and urinary tract infections, decreased fluid volume, and increased urination while taking this medication. Rarely, severe metabolic abnormalities known as ketoacidosis may occur, and if symptoms appear, immediate consultation with medical professionals is necessary. Elderly patients or those at risk of fluid volume loss should be cautious of dehydration or hypotension, and monitoring of fluid status is recommended. This medication has been reported to cause liver damage, so liver health should also be carefully monitored. Caution is required during driving or operating machinery due to the risk of hypoglycemia, especially when used in conjunction with insulin and similar products. Women who are pregnant or breastfeeding should avoid taking this medication, and it should be immediately discontinued upon confirmation of pregnancy. Children should not use this medication as safety and efficacy have not been established. No specific toxic symptoms have been reported in cases of overdose, but appropriate treatment is needed based on clinical status. This medication should be kept out of the reach of children, and transferring it to another container should be avoided to maintain quality and safety.

Serious side effects

• Urticaria
• angioedema
• ketoacidosis
• urinary tract sepsis
• pyelonephritis
• perineal necrosis
• severe allergic reactions
• severe skin adverse reactions
• severe edema or urination abnormalities
• liver abnormalities (jaundice)

Mild side effects

Constipation, itching, rash, hypoglycemia, vulvovaginal candidiasis, vulvitis, glans inflammation and other genital infections, increased urination, difficulty urinating, interstitial nephritis, thirst, increased serum lipids, increased serum creatinine, decreased glomerular filtration rate, increased hematocrit, diarrhea, nausea, gastric ulcer, colitis, vomiting, ischemic colitis, gastrointestinal bleeding, soft tissue infection, appendiceal abscess, appendicitis, chronic otitis media, peritonsillar abscess

This medication should be stored in a tightly sealed container to prevent air and moisture ingress and should be kept at a temperature between 1 to 30 degrees Celsius. Storing it this way will help maintain its effectiveness for a longer period.

Appearance

Pale yellow, round film-coated tablet

Package unit

30 tablets/box [(10 tablets/PTP×3)]